Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections
Ger T. Rijkers, Jean‐Luc Murk, Bas Wintermans, Bieke van Looy, Marcel van den Berge, Jacobien Veenemans, Joep Stohr, Chantal Reusken, Pieter van der Pol, Johan Reimerink
The Journal of Infectious Diseases, 2020
Abstract
This research paper explore the methodology and findings associated with The Journal of Infectious Diseases. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).
- Attenuation of Antibody Titers from 3 to 6 Months after the Second Dose of the BNT162b2 Vaccine Depends on Sex, with Age and Smoking Risk Factors for Lower Antibody Titers at 6 Months 2021
- Brief Report: Prediction of Serum HIV-1 Neutralization Titers After Passive Administration of VRC01 2019
- An Analysis of Neutralization Reaction of Interferon by Antibody: A Proposal on the Expression of Neutralization Titer 1980
- Anti-Human Growth Hormone (HGH) Antibody Determination in HGH-treated Patients 1978
- The dynamic change of chicken serum antibody after inject IgY 2012
- Neutralizing Antibody Response and SARS Severity 2005
- Serological Responses in Patients with Severe Acute Respiratory Syndrome Coronavirus Infection and Cross-Reactivity with Human Coronaviruses 229E, OC43, and NL63 2005
- Specific serology for emerging human coronaviruses by protein microarray 2013
- Evaluation of MERS-CoV Neutralizing Antibodies in Sera Using Live Virus Microneutralization Assay 2019
- Profiling of humoral immune responses to influenza viruses by using protein microarray 2011